|

Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

RECRUITINGSponsored by National Cancer Institute, Naples
Actively Recruiting
SponsorNational Cancer Institute, Naples
Started2022-05-19
Est. completion2027-11-19
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05817227

Summary

This is multicentric, spontaneous, observational, retrospective and prospective study.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* TNBC breast cancer patients, before any drug treatment
* healthy women aged 25-60

Exclusion Criteria:

* donors suffering from diabetes, hypertension, active infectious states, HIV infection, Hepatitis B or C, chronic inflammatory diseases, current or previous neoplasms, heart disease or drug treatment.

Conditions2

Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.